| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Turner Christopher Durant is a Chief Medical Officer at Nuvalent, Inc.. Recent SEC Form 4 filings include 0 buys and 21 sells.
Estimated insider holdings value: $9.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | NUVL Nuvalent, Inc. | Chief Medical Officer | Sell | 7,417 | $97.25 | $721,320.39 | -1.8% | +6.7% | - | |
| Jan 6, 2025 | NUVL Nuvalent, Inc. | Chief Medical Officer | Sell | 4,016 | $79.68 | $320,009.01 | -2.0% | -17.2% | +24.5% | |
| Oct 4, 2023 | NUVL Nuvalent, Inc. | Chief Medical Officer | Sale+OE | 7,995 | $54.04 | $432,030.80 | -7.3% | +32.3% | +80.0% | |
| Jul 28, 2023 | NUVL Nuvalent, Inc. | Chief Medical Officer | Sale+OE | 5,030 | $47.95 | $241,198.70 | -14.8% | +11.2% | +68.3% | |
| Jul 24, 2023 | NUVL Nuvalent, Inc. | Chief Medical Officer | Sale+OE | 300 | $46.81 | $14,044.00 | -1.0% | +9.3% | +79.3% | |
| Jun 5, 2023 | NUVL Nuvalent, Inc. | Chief Medical Officer | Sale+OE | 10,235 | $44.86 | $459,142.10 | -41.4% | +8.8% | +59.8% |